Pain, Back
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Clarity PharmaceuticalsAustralia - Eveleigh
1 programDrug- free, non-invasive patchN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
Clarity PharmaceuticalsDrug- free, non-invasive patch
Human BioSciencesPrimary Spine Provider Model
Oregon TherapeuticsResearch electrode
Clinical Trials (3)
Total enrollment: 1,960 patients across 3 trials
Relieving Pain and Improving Sleep: Evaluating Topical Pain Relief and Sleep Patches
Start: Sep 2024Est. completion: Aug 2026150 patients
N/ACompleted
Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
Start: Mar 2023Est. completion: Sep 20261,800 patients
N/ACompleted
Brown Adipose Tissue Activation by Spinal Cord Stimulation
Start: Feb 2021Est. completion: Dec 202910 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,960 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.